Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

NCT03093870 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

151

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

DRUG: Varlitinib
DRUG: Capecitabine
DRUG: Placebo (for Varlitinib)

Sponsor

ASLAN Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]